These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21636299)

  • 1. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
    Völkl TM; Rauh M; Schöfl C; Dörr HG
    Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Cunha HM; Elias LL; Camacho-Hübner C; Moreira AC; Martinelli CE
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):94-101. PubMed ID: 15212650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Körner A; Kiess W; Kratzsch J; Dörr HG
    Acta Paediatr; 2009 May; 98(5):885-91. PubMed ID: 19236311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
    Völkl TM; Simm D; Körner A; Rascher W; Kiess W; Kratzsch J; Dörr HG
    Eur J Endocrinol; 2009 Feb; 160(2):239-47. PubMed ID: 19004982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
    Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency.
    Ertl DA; Chen J; Gleiss A; Janu D; Sagmeister S; Raimann A; Riedl S; Haeusler G
    Horm Res Paediatr; 2020; 93(6):371-379. PubMed ID: 33341813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum levels of acid-labile subunit in patients with anorexia nervosa.
    Fukuda I; Hotta M; Hizuka N; Takano K; Ishikawa Y; Asakawa-Yasumoto K; Tagami E; Demura H
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2034-6. PubMed ID: 10372706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin-like growth factors (IGFs), IGF-Binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome.
    de Boer L; Hoogerbrugge CM; van Doorn J; van Buul-Offers SC; Karperien M; Wit JM
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):615-27. PubMed ID: 15198293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I; Hizuka N; Itoh E; Yasumoto K; Ishikawa Y; Murakami Y; Sata A; Takano K
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
    Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
    Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-labile subunit levels and the association with response to growth hormone treatment in short children born small for gestational age.
    Renes JS; van Doorn J; Breukhoven PE; Lem AJ; de Ridder MA; Hokken-Koelega AC
    Horm Res Paediatr; 2014; 81(2):126-32. PubMed ID: 24481285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
    Cisternino M; Draghi M; Lauriola S; Scarcella D; Bernasconi S; Cavallo L; De Luca F; Lomeo A; Tatò L
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.